Gene Therapies for Eternal Youth

Imagine a not-so-distant future, when a 60-year-old man named John Doe goes to the doctor to replace a faulty gene or insert a whole new gene into his body — something that cures his diabetes, for instance. This is no pipe dream. So far, gene therapy <a href="https://www.technologyreview.com/2023/05/19/1073394/the-fda-just-approved-krystal-drip-on-gene-therapy-that-helps-butterfly-children/" rel="noopener ugc nofollow" target="_blank">has been approved</a> by the U.S. Food and Drug Administration (FDA) for only a couple of applications like rare inherited diseases and blood cancer. That said, more than 2,000 clinical trials are taking place in 2023, with 200 of them having already reached phase 3 clinical trials. A slew of <a href="https://invivo.pharmaintelligence.informa.com/IV146781/The-Cell-And-Gene-Therapy-Sector-In-2023-A-Wave-Is-Coming--Are-We-Ready" rel="noopener ugc nofollow" target="_blank">upcoming gene therapies</a> could be approved — possibly in the months to come — in the United States and Europe, targeting everything from sickle cell disease and hemophilia to metastatic skin cancer. In this future, gene therapy will be approved for everything we can imagine — and many things we can’t. <a href="https://medium.com/neodotlife/gene-therapies-for-eternal-youth-43589506ac42">Click Here</a>